The Authors report their experience of five years in the medical treatment of impotence with PGE1 and papaverine. 83.9% of patients have been treated and the results are positive in 76%. There are no negative effects nor complications.
KeoghE.J., WattersG.R., TullochA.G.S., : The diagnosis and treatment of impotence. Med. J. Aust., 148: 494–498, 1988.
2.
LueT.F., TanaglioE.A.: Physiology of erection and pharmacological management of impotence. J. Urol., 137: 829–836, 1987.
3.
RaboyA., CombsA., GodecC.J., IrwinM.: Comparison of Papaverine and Prostaglandine E1 in impotent patients. J. Urology, 143: 303A, 1990.
4.
SidiA.A., CameronJ.S., DuffyL.M., LangeP.H.: Intracavernous drug-induced erection in management of male erectile dysfunction. Experience with 100 patients. J. Urol., 135: 704–706, 1986.
5.
LueT.F.: Impotence: a patient's goal-directed approach to treatment. World. J. Urol., 8: 67, 1990.
